These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31525463)
1. A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome. Kiaie N; Gorabi AM; Penson PE; Watts G; Johnston TP; Banach M; Sahebkar A Drug Discov Today; 2020 Jan; 25(1):58-72. PubMed ID: 31525463 [TBL] [Abstract][Full Text] [Related]
2. Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management. Mancini GBJ; Gupta M; Tsigoulis M; Cannon CP; Genest J; Ray KK; Santos RD; Watts GF; Raggi P Atherosclerosis; 2017 Aug; 263():112-118. PubMed ID: 28623740 [TBL] [Abstract][Full Text] [Related]
3. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016. Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139 [TBL] [Abstract][Full Text] [Related]
4. Current pharmacotherapies for atherosclerotic cardiovascular diseases. Park JG; Oh GT Arch Pharm Res; 2019 Mar; 42(3):206-223. PubMed ID: 30725249 [TBL] [Abstract][Full Text] [Related]
6. Nano-sponge-like liposomes remove cholesterol crystals for antiatherosclerosis. Gong F; Wang Z; Mo R; Wang Y; Su J; Li X; Omonova CTQ; Khamis AM; Zhang Q; Dong M; Su Z J Control Release; 2022 Sep; 349():940-953. PubMed ID: 35870569 [TBL] [Abstract][Full Text] [Related]
7. National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk. Orringer CE; Jacobson TA; Maki KC J Clin Lipidol; 2019; 13(6):860-872. PubMed ID: 31787586 [TBL] [Abstract][Full Text] [Related]
9. Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice. Chono S; Tauchi Y; Deguchi Y; Morimoto K J Drug Target; 2005 May; 13(4):267-76. PubMed ID: 16051539 [TBL] [Abstract][Full Text] [Related]
10. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. Nordestgaard BG Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957 [TBL] [Abstract][Full Text] [Related]
11. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease. Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study. Kim H; Kim S; Han S; Rane PP; Fox KM; Qian Y; Suh HS BMC Public Health; 2019 Aug; 19(1):1112. PubMed ID: 31412823 [TBL] [Abstract][Full Text] [Related]
14. Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography. Hyafil F; Feldman L; Le Guludec D; Fayad ZA Mt Sinai J Med; 2012; 79(6):689-704. PubMed ID: 23239208 [TBL] [Abstract][Full Text] [Related]
16. Novel directions in inflammation as a therapeutic target in atherosclerosis. Verweij SL; van der Valk FM; Stroes ES Curr Opin Lipidol; 2015 Dec; 26(6):580-5. PubMed ID: 26382552 [TBL] [Abstract][Full Text] [Related]
17. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options. Berman AN; Blankstein R Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838 [TBL] [Abstract][Full Text] [Related]
18. Ischemic Event Rates in Very-High-Risk Adults. Colantonio LD; Shannon ED; Orroth KK; Zaha R; Jackson EA; Rosenson RS; Exter J; Mues KE; Muntner P J Am Coll Cardiol; 2019 Nov; 74(20):2496-2507. PubMed ID: 31727288 [TBL] [Abstract][Full Text] [Related]
19. Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease? Kim G; Youn HJ; Choi YS; Jung HO; Chung WS; Kim CM Clin Interv Aging; 2015; 10():1111-9. PubMed ID: 26185430 [TBL] [Abstract][Full Text] [Related]
20. Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease. Chamberlain AM; Cohen SS; Weston SA; Fox KM; Xiang P; Killian JM; Qian Y Am J Cardiol; 2019 Jun; 123(11):1739-1744. PubMed ID: 30948001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]